» Articles » PMID: 12762968

Fat-induced Liver Insulin Resistance

Overview
Journal Curr Diab Rep
Publisher Current Science
Specialty Endocrinology
Date 2003 May 24
PMID 12762968
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

In vitro studies have established that free fatty acids (FFAs) are important regulators of hepatic glucose metabolism. FFAs can increase hepatic glucose release by increasing the amount and activity of glucose-6-phosphatase and multiple gluconeogenic enzymes. Elevated FFAs can also potentially decrease hepatic glucose uptake by decreasing hepatic glucokinase activity. In vivo studies in both animals and humans have shown a close correlation between changes in plasma FFAs and endogenous glucose production (EGP). Intervention studies have established that changes in plasma FFAs are accompanied by changes in the relative contribution of gluconeogenesis and glycogenolysis to EGP. The effects of a change in FFAs on EGP itself are more evident when compensatory changes in insulin secretion are prevented or when insulin secretion is impaired (eg, diabetes mellitus). The effects of elevated FFAs on splanchnic glucose uptake are less clear, in that they appear to have no effect in nondiabetic humans and may impair uptake in people with type 2 diabetes.

Citing Articles

Association Between the Triglyceride-Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study.

Liu J, Guan L, Zhao M, Li Q, Song A, Gao L Diabetes Metab Syndr Obes. 2021; 14:2829-2839.

PMID: 34188506 PMC: 8232855. DOI: 10.2147/DMSO.S316864.


Palmitic acid mediates hypothalamic insulin resistance by altering PKC-theta subcellular localization in rodents.

Benoit S, Kemp C, Elias C, Abplanalp W, Herman J, Migrenne S J Clin Invest. 2009; 119(9):2577-89.

PMID: 19726875 PMC: 2735917. DOI: 10.1172/JCI36714.


Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production.

Kehlenbrink S, Tonelli J, Koppaka S, Chandramouli V, Hawkins M, Kishore P Am J Physiol Endocrinol Metab. 2009; 297(1):E165-73.

PMID: 19417129 PMC: 2711655. DOI: 10.1152/ajpendo.00001.2009.


Modulation of human insulin receptor substrate-1 tyrosine phosphorylation by protein kinase Cdelta.

Greene M, Morrice N, Garofalo R, Roth R Biochem J. 2003; 378(Pt 1):105-16.

PMID: 14583092 PMC: 1223928. DOI: 10.1042/BJ20031493.

References
1.
Rebrin K, Steil G, Getty L, Bergman R . Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes. 1995; 44(9):1038-45. DOI: 10.2337/diab.44.9.1038. View

2.
Ekberg K, Landau B, Wajngot A, Chandramouli V, Efendic S, Brunengraber H . Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes. 1999; 48(2):292-8. DOI: 10.2337/diabetes.48.2.292. View

3.
Lam T, Yoshii H, Haber C, Bogdanovic E, Lam L, Fantus I . Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta. Am J Physiol Endocrinol Metab. 2002; 283(4):E682-91. DOI: 10.1152/ajpendo.00038.2002. View

4.
Paul P, ISSEKUTZ Jr B, MILLER H . Interrelationship of free fatty acids and glucose metabolism in the dog. Am J Physiol. 1966; 211(6):1313-20. DOI: 10.1152/ajplegacy.1966.211.6.1313. View

5.
Reaven G, Chang H, Ho H, Jeng C, Hoffman B . Lowering of plasma glucose in diabetic rats by antilipolytic agents. Am J Physiol. 1988; 254(1 Pt 1):E23-30. DOI: 10.1152/ajpendo.1988.254.1.E23. View